|
|
|
Volumn 101, Issue 5, 2010, Pages 319-328
|
|
Economic impact simulation analysis of use of tigecycline, as appropriate, in first-course antibiotic therapy for complicated intra-abdominal infections in intensive care patients
|
|
Author keywords
Anti bacterial agents; Cost benefit analysis; Intensive care unit; Tigecycline
|
|
Indexed keywords
TIGECYCLINE;
ABDOMINAL INFECTION;
ANTIBIOTIC THERAPY;
ARTICLE;
COST BENEFIT ANALYSIS;
COST CONTROL;
DISEASE SEVERITY;
DRUG COST;
FIRST COURSE ANTIBIOTIC THERAPY;
HOSPITAL COST;
HUMAN;
INTENSIVE CARE;
ITALY;
SIMULATION;
TREATMENT FAILURE;
ANTI-BACTERIAL AGENTS;
BACTERIAL INFECTIONS;
CLINICAL PROTOCOLS;
COST-BENEFIT ANALYSIS;
DRUG COSTS;
HOSPITAL COSTS;
HUMANS;
INTENSIVE CARE;
INTENSIVE CARE UNITS;
LENGTH OF STAY;
MINOCYCLINE;
RETREATMENT;
TREATMENT OUTCOME;
|
|
EID: 78650562908
PISSN: 00264806
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (1)
|
|
References (0)
|
